SHARE CAPITAL AND STOCK OPTIONS (Narrative) (Details) (USD $)	0 Months Ended	6 Months Ended
	Sep. 19, 2012	Dec. 31, 2012	Jun. 30, 2012
Stockholders Equity Note [Line Items]
Number of warrants exercised		718,213
Number of common stock shares issued related to warrants		446,423
Advance payment for leasehold improvements		$ 1,305	$ 2,400
Additional shares commited for issuance		75
Class of Warrant or Right [Line Items]
Costs related to private placement		2,694
Units sold in public offering	8,000,000
Public offering, number of shares per unit	1
Public offering, number of warrants per unit	1
Public offering, purchase price per unit	$ 4.0
Public offering, number of shares per one warrant	0.35
Limited period, number of common stock options, underwriters	1,200,000
Maximum of options and warrants	420,000
Proceeds from issuance of shares	34,106
Warrant exercise price per share	$ 5.0
Biopharmax [Member]
Stockholders Equity Note [Line Items]
Shares issued in advance for services		1,500,000
Shares issued in advance for services, value, sold		5,071
Warrant [Member] | Investor [Member]
Stockholders Equity Note [Line Items]
Number of common stock shares issued related to warrants		1,027,247
Proceeds received from warrants		$ 1,679